(F11.

,
,
. , ,
, -, ,
-
A. , , ,



,
.


.


,
,

.


.

.


.










.
(
).







2

,
, .

.
:

.
, ( ).
0.4mg 0,8mg 3-10
10mg, .
.

.

.

:

.
,
(.. ).

,
(). .

, ,

.
.

,

.

-
.

. ,
.
,
.

.
: 10-30mg
: 5-10mg 3-5
: 60-100mg
6-8 .

.

.
, (
QT, )
.
:

.
QT 450ms



QT.

, , .


/ .

/ 4:1.
0,4 mg, 2 mg 8 mg
.
4-32 mg
16 mg. 2-4mg
.
1-2 .
:
8mg
,
4mg

2-4mg .


.

, , .
.

.

.

.
:


/
( ,
)
12
( )

,
,
.

,
.

(8-10 ).
25mg/
50mg .


, , .

.

.
: 6-12 .

.
: 48-72
:
7-20


, ,

.
, , , ,
, , , , , , ,
, .



.



.

.

,
,
.
, ,

, .


(40-60mg , 5-10mg/)

(8-32mg , 2mg/ 10-14 )

2

, ,
, , , .
4-6 0,1mg mg
: ,
: , .

,
,
,
( ) .

.

,
.
.
7



, .

,
.

,
.
:
2-5
0,1-0,5mg
8mg

(F11.4 ,
F11.5 , F11.7
, F11.72 ).

,
.

Galanter ., The American Psychiatric Publishing Textbook of Substance Abuse

Treatment, Fourth Edition, 2008

Schuckit, M. A, Drug And Alcohol Abuse: A Clinical Guide To Diagnosis And

Treatment (6th edition).2010 , Springer

National Institute for Clinical Excellence. Methadone and buprenorphine for the
management of opioid dependence. www.nice.org.uk. 2007.


Department of Health. Drug misuse and dependence. UK guidelines on clinical
management. 2007.

Department of Health. Drug misuse and dependence: guidelines on clinical

management. Norwich: Department of Health; 1999